Novo Nordisk trial ‘own goal’ sparks flurry of analyst downgrades
- Posted on February 24, 2026
- By CNBC
- 2 Views
Novo Nordisk trial ‘own goal’ sparks flurry of analyst downgrades
Analysts raced to cut price targets on an already struggeling Novo Nordisk stock following disappointing trial results for its weight loss candidate CagriSema.
